TSX-V: CHO
www.chinahealthlabs.com
Financial Results for the First Quarter Ended March 31, 2013 to be Released on May 30, 2013
TORONTO, May 29, 2013 /CNW/ - China Health Labs & Diagnostics Ltd. ("China Health" or the "Company") (TSXV: CHO), is pleased to announce that on May 30, 2013, after market close, it will be releasing the results of the first quarter ended March 31, 2013, and will be hosting an investor conference call on Friday, May 31, 2013 at 10:00am (Eastern Time). The purpose of this conference call will be to provide investors with an update of the first quarter results of the Company. Representing China Health on the conference call will be:
|
|
|
|
|
Mr. Shiping (Wilson) Yao, President and Chief Executive Officer
Ms. Judyanna Chen, Chief Financial Officer
Mr. Chao Zhang, Vice President, Finance (Chief Financial Officer, effective May 31, 2013)
Mr. Kim Oishi, Member of the Board of Directors |
Following the update, a question and answer session will be held. To participate, the dial-in instructions are as follows:
| DATE: |
Friday, May 31, 2013
|
| TIME: |
10:00am, Eastern Time |
| Participant Dial-In Number(s): |
|
North America Toll-Free Dial-In Number: |
1 (888) 231-8191 |
|
For Toronto and International Callers: |
1 (647) 427-7450 |
A Taped Replay will be available from 1:00 pm Eastern Time on May 31, 2013 to 11:59 pm Eastern Time on June 14, 2013.
Taped Replay Toll Free Number: 1.855.859.2056
| Taped Replay Local Dial-in Numbers: |
| (778) 371-8506 |
(416) 849-0833 |
(514) 807-9274 |
| (403) 451-9481 |
(613) 667-0035 |
(902) 455-3955 |
Taped Replay Password: 86571508
About China Health Labs & Diagnostics Ltd.
China Health, operating in China as the Biochem Group, is a leading diagnostic lab solution provider for the public healthcare industry in China. The Company develops and sells Biochem Group branded and third-party medical diagnostic products and services to diagnostic facilities in China. Customers include large urban hospitals, rural hospitals, Chinese military and rescue operations, the Beijing government and third-party distributors.
In 2012, China Health had revenue of approximately $45.8 million, and intends to expand its business by focusing its efforts on expanding its sales network in three areas where it provides proprietary solutions, has limited competition and that are supported by Chinese government policy and budgets: BK Clinlab total lab solutions for rural hospitals and clinics, POCT solutions for military and emergency rescue services, and food safety solutions for large cities in China.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and information that are based on the beliefs of management and reflect China Health's current expectations. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this news release includes information relating to the expansion of the Company's business by focusing on expanding its sales network to additional Chinese provinces and cities in the areas where it has proprietary products, limited competition and strong government support.. The forward-looking information is based on certain assumptions, which could change materially in the future, including the assumption that the Company's products and services, operations, market, marketing plans and strategies, competitive conditions, future developments and proprietary protections continue as projected. Such statements and information reflect the current view of China Health with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risk that the Company may not be able to expand its business as expected through its sales network in any of the areas in which it has proprietary products, limited competition and strong government support. These and other risks are further described under "Risk Factors" in the Company's management's discussion and analysis dated April 30, 2013, which is available on SEDAR and may be accessed at www.sedar.com. When relying on China Health's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. China Health has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to above will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
SOURCE: CHINA HEALTH LABS & DIAGNOSTICS
